CSE Bulletin: Appointment of Market Maker - Mind Cure Health Inc.

Overview

Mind Cure (CSE:MCUR,OTCQB:MCURF) is a mental health and wellness company that is dedicated to investigating the potential of psychoactive, psychedelic, and nootropic compounds to treat what the World Health Organization (WHO) has labeled a global mental health crisis. The company has developed a unique “Five Spheres” framework to structure its approach to mental health investigation. The five spheres cover Mind Cure’s interest in psychedelic research, digital therapeutics, psychedelic drug discovery, formulation and nootropics.

According to the WHO, roughly 450 million people worldwide are suffering from mental or neurological disorders. In Canada, the total cost from mental health problems and disorders has been conservatively estimated to be at least C$50 billion per year, representing 2.8 percent of the country’s GDP. The economic burden of mental health problems has led the United Nations to urge governments to seek, develop and implement affordable solutions.